These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 14455898)

  • 21. Agar gel precipitin analyses in laboratory-acquired tularemia.
    VOSTI KL; WARD MK; TIGERTT WD
    J Clin Invest; 1962 Jul; 41(7):1436-45. PubMed ID: 13926832
    [No Abstract]   [Full Text] [Related]  

  • 22. [Study of the immunizing effect of the virulent Tularemia strain treated by streptomycin].
    Brikman DI
    Antibiotiki; 1971 Sep; 16(9):827-31. PubMed ID: 5139456
    [No Abstract]   [Full Text] [Related]  

  • 23. [Studies on the pathogenesis of tularemia. III. Survival of B. tularense in the organism of normal and immunized rabbits].
    SKRODZKI E
    Biul Inst Med Morsk Gdansk; 1961; 12():45-50. PubMed ID: 13913724
    [No Abstract]   [Full Text] [Related]  

  • 24. [Improved preparation of dry living tularemia vaccine].
    KOLIADITSKAIA LS; SHMURYGINA AA
    Zh Mikrobiol Epidemiol Immunobiol; 1957 Oct; 28(10):84-9. PubMed ID: 13531893
    [No Abstract]   [Full Text] [Related]  

  • 25. Hemagglutination test in tularemia: results in 56 vaccinated persons with laboratory acquired infection.
    CHARKES ND
    J Immunol; 1959 Aug; 83():213-20. PubMed ID: 13809306
    [No Abstract]   [Full Text] [Related]  

  • 26. [Tularemia, "volume" two].
    Macela A
    Epidemiol Mikrobiol Imunol; 1998 Aug; 47(3):103-20. PubMed ID: 9748768
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies with tularemia vaccines in volunteers. VI. Assessment of role of properdin in resistance.
    CARLISLE HN; SASLAW S
    Proc Soc Exp Biol Med; 1962 Jul; 110():603-5. PubMed ID: 13876614
    [No Abstract]   [Full Text] [Related]  

  • 28. [Agglutination and allergic reactions following revaccination against tularemia].
    BUIALO SG; SLESARENKO VV
    Zh Mikrobiol Epidemiol Immunobiol; 1956 Sep; 27(9):44-8. PubMed ID: 13393677
    [No Abstract]   [Full Text] [Related]  

  • 29. [Properties of living dry vaccine against tularemia NIIEG and their relation to the duration of its preservation].
    MARTINEVSKII IL
    Zh Mikrobiol Epidemiol Immunobiol; 1956 Sep; 27(9):20-2. PubMed ID: 13393672
    [No Abstract]   [Full Text] [Related]  

  • 30. [A contribution to the serology of tularemia. (Hemagglutination, agglutination, para-agglutination and agglutinin absorption)].
    KNOTHE H; HAVEMEISTER G
    Zentralbl Bakteriol; 1961 Jan; 181():80-102. PubMed ID: 13831003
    [No Abstract]   [Full Text] [Related]  

  • 31. Prophylactic effectiveness of live and killed tularemia vaccines. I. Production of vaccine and evaluation in the white mouse and guinea pig.
    EIGELSBACH HT; DOWNS CM
    J Immunol; 1961 Oct; 87():415-25. PubMed ID: 13889609
    [No Abstract]   [Full Text] [Related]  

  • 32. [Immunologic reactions and their duration in human following epicutaneous vaccination with living tularemia vaccine prepared on egg yolk].
    MOROZ AP; KHYZHYNS'KA OP; BUIALO Kh
    Mikrobiol Zh; 1955; 17(3):40-5. PubMed ID: 13430402
    [No Abstract]   [Full Text] [Related]  

  • 33. Antimicrobial activity of mosquito cecropin peptides against Francisella.
    Kaushal A; Gupta K; Shah R; van Hoek ML
    Dev Comp Immunol; 2016 Oct; 63():171-80. PubMed ID: 27235883
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Result of mass application on human subjects of dry tularemia vaccine prepared from reduced Gaiskii's No. 15 and Emelianova's No. 155 strains].
    OLSUF'EV NG; EMEL'IANOVA OS; UGLOVOI GP; SIL'CHENKO VS; BORODIN VP; SAMSONOVA AP; KONKINA NS; SHELANOVA GM; LEVACHEVA ZA; TSAREVA MI; ZYKINA NA; LEBEDEVA TF
    Zh Mikrobiol Epidemiol Immunobiol; 1958 Mar; 29(3):52-7. PubMed ID: 13570442
    [No Abstract]   [Full Text] [Related]  

  • 35. [Experimental study of susceptibility and infectious sensitivity to tularemia of the lemming (Dicrostonyx torquatus Pall].
    Algazin IP; Marenko VF
    Zh Mikrobiol Epidemiol Immunobiol; 1976 Jul; (7):110-2. PubMed ID: 1007735
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [On some cases of tularemia found in Lombardy. Sero-immunological and histopathological observations].
    Bianchi L
    G Mal Infett Parassit; 1966 Jul; 18(7):443-57. PubMed ID: 5990241
    [No Abstract]   [Full Text] [Related]  

  • 37. [Tularemia vaccine strain is a potential vector].
    Pavlov VM; Mokrievich AN; Noskov AN; Urakov NN
    Vestn Ross Akad Med Nauk; 1997; (6):30-2. PubMed ID: 9289276
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expansion and retention of pulmonary CD4
    Roberts LM; Wehrly TD; Crane DD; Bosio CM
    Vaccine; 2017 May; 35(19):2575-2581. PubMed ID: 28372827
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Successful protection against tularemia in C57BL/6 mice is correlated with expansion of Francisella tularensis-specific effector T cells.
    Griffin AJ; Crane DD; Wehrly TD; Bosio CM
    Clin Vaccine Immunol; 2015 Jan; 22(1):119-28. PubMed ID: 25410207
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipoxin A4, a 5-lipoxygenase pathway metabolite, modulates immune response during acute respiratory tularemia.
    Singh A; Rahman T; Bartiss R; Arabshahi A; Prasain J; Barnes S; Musteata FM; Sellati TJ
    J Leukoc Biol; 2017 Feb; 101(2):531-542. PubMed ID: 27630217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.